HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a homogeneous screening assay for automated detection of antiviral agents active against severe acute respiratory syndrome-associated coronavirus.

Abstract
The severity and global spread of the 2003 outbreak of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) highlighted the risks to human health posed by emerging viral diseases and emphasized the need for specific therapeutic agents instead of relying on existing broadly active antiviral compounds. The development of rapid screening assays is essential for antiviral drug discovery. Thus, a screening system for anti-SARS-CoV agents was developed, which evaluated compound potency, specificity and cytotoxicity at the initial screening phase. Cell lines were engineered to constitutively express an enhanced green fluorescent protein (EGFP) and used to detect (1) antiviral potency in SARS-CoV infection tests; (2) antiviral specificity in tests using the porcine coronavirus transmissible gastroenteritis virus (TGEV); and (3) cytotoxicity in the same assays without virus challenge. The assay system involves minimal manipulation after assay set-up, facilitates automated read-out and minimizes risks associated with hazardous viruses. The suitability of this assay system in drug discovery was demonstrated by screening of 3388 small molecule compounds. The results show that these assays can be applied to high-throughput screening for identification of inhibitors selectively active against SARS-CoV.
AuthorsTania Ivens, Christel Van den Eynde, Koen Van Acker, Erik Nijs, Géry Dams, Eva Bettens, Asa Ohagen, Rudi Pauwels, Kurt Hertogs
JournalJournal of virological methods (J Virol Methods) Vol. 129 Issue 1 Pg. 56-63 (Oct 2005) ISSN: 0166-0934 [Print] Netherlands
PMID15961169 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Green Fluorescent Proteins
Topics
  • Antiviral Agents (analysis, chemistry, metabolism, pharmacology)
  • Cell Line
  • Drug Evaluation, Preclinical
  • Green Fluorescent Proteins
  • Severe acute respiratory syndrome-related coronavirus (drug effects, physiology)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: